文献速递细菌感染、耐药与抗菌药物医院感染防控

单间接触隔离对多重耐药大肠埃希菌医院获得与传播的影响:血液肿瘤病房前瞻性多中心队列研究

Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards.
PubMed 文献 · Clin Microbiol Infect · 2019-01-12

该前瞻性多中心队列研究在4个血液肿瘤病房比较单间接触隔离(SCP)对氟喹诺酮类非敏感三代头孢菌素耐药大肠埃希菌(F3GCR-EC)医院获得定植或血流感染的影响。12个月内纳入NCP站点1386例和SCP站点1582例患者,结果显示SCP对医院获得或患者间传播无显著影响。

要点

  • SCP对F3GCR-EC医院获得定植或BSI无显著影响。
  • SCP对患者间传播无显著影响,两站点各3例。
  • 预防1例患者间传播需筛查3729例患者。

核心结论

  • 在高危血液肿瘤患者中,单间接触隔离对F3GCR-EC的医院获得或患者间传播无显著影响。

研究设计与样本

  • 前瞻性多中心队列研究,在4个血液肿瘤病房开展,2个站点实施SCP(单间、手套、隔离衣),2个站点不实施。
  • 共纳入NCP站点1386例患者和SCP站点1582例患者,进行主动筛查和分子分型(含全基因组测序和核心基因组MLST)评估传播。

主要发现

  • F3GCR-EC医院获得在NCP站点为22/1386(1.59%),SCP站点为16/1582(1.01%),p 0.191。
  • F3GCR-EC血流感染在NCP站点为3/1386(0.22%),SCP站点为4/1582(0.25%),p 1.000。
  • 患者间传播在NCP和SCP站点各3例,p 1.000。
  • 预防1例F3GCR-EC患者间传播需筛查的患者数为3729。

临床怎么用

  • 在该高危 setting 中,SCP对F3GCR-EC医院获得和传播无显著影响,可重新评估常规单间接触隔离的必要性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Colonization and infection with third-generation cephalosporin-resistant Escherichia coli (3GCR-EC) are frequent in haematological and oncological patients. In this high-risk setting, German guidelines recommend single-room contact precautions (SCP) for patients with 3GCR-EC that are non-susceptible to fluoroquinolones (F3GCR-EC). However, this recommendation is controversial, as evidence is limited. METHODS: We performed a prospective, multicentre cohort study at four haematology and oncology departments assessing the impact of SCP on hospital-acquired colonization or bloodstream infection (BSI) with F3GCR-EC. Two sites performed SCP for F3GCR-EC patients including single rooms, gloves and gowns (SCP sites), and two did not (NCP sites). Active screening for 3GCR-EC was performed and isolates were characterized with molecular typing methods including whole genome sequencing and core genome multiple locus sequence typing to assess patient-to-patient transmission. Potential confounders were assessed by competing-risk regression analysis. RESULTS: Within 12 months, 1386 patients at NCP sites and 1582 patients at SCP sites were included. Hospital-acquisition of F3GCR-EC was observed in 22/1386 (1.59%) and 16/1582 (1.01%) patients, respectively (p 0.191). There were 3/1386 (0.22%) patients with BSI caused by F3GCR-EC at NCP sites and 4/1582 (0.25%) at SCP sites (p 1.000). Patient-to-patient transmission occurred in three cases at NCP and SCP sites each (p 1.000). The number of patients needed to screen in order to prevent one patient-to-patient transmission of F3GCR-EC was determined to be 3729. CONCLUSIONS: Use of SCP had no significant impact on hospital-acquisition or patient-to-patient transmission of F3GCR-EC in this high-risk setting.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Biehl LM, Higgins P, Wille T, et al. Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards. Clin Microbiol Infect. 2019. PMID: 30641228. doi:10.1016/j.cmi.2018.12.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。